AltruBio Competitors and Similar CompaniesClear all
Biocon's competitors and similar companies include Takeda Oncology, Kyowa Kirin and 3sbio.
 Takeda Oncology Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |||
Founding Date | Founding Date 1978 | Founding Date 1993 | Founding Date 2008 | Founding Date 1993 |
Type | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Cambridge, US HQ | Locations Shenyang, CN HQ | |
Employees | Employees 16,5612% increase | Employees 1,6441% decrease | Employees 5,669 | Employees 5,577 |
Financial | ||||
Revenue (est.) | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) N/A | Revenue (est.) ¥496.8b (FY, 2025) | Revenue (est.) ¥17.7b (FY, 2025) |
Cost of goods | Cost of goods ₹56.9b (FY, 2026) | Cost of goods N/A | Cost of goods ¥114.3b (FY, 2025) | Cost of goods ¥818m (FY, 2025) |
Gross profit | Gross profit ₹115.8b (FY, 2026) | Gross profit N/A | Gross profit ¥383.4b (FY, 2025) | Gross profit ¥17b (FY, 2025) |
Net income | Net income ₹3.7b (FY, 2026) | Net income N/A | Net income ¥67b (FY, 2025) | Net income ¥9.1b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Takeda Oncology
HQ
Cambridge, US
Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.
View companyKyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company
3sbio
HQ
Shenyang, CN
Employees
5,577
3sbio (三生制药集团) is a company that develops biopharmaceuticals.
View company